This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Droxidopa

Read time: 1 mins
Marketing start date: 23 Dec 2024
...
 

Summary of product characteristics


Effective Time

20220825

Version

2

Spl Product Data Elements

Droxidopa Droxidopa DROXIDOPA DROXIDOPA FD&C BLUE NO. 1 FD&C RED NO. 40 FERROSOFERRIC OXIDE GELATIN MAGNESIUM STEARATE MANNITOL POTASSIUM HYDROXIDE PROPYLENE GLYCOL SHELLAC SODIUM LAURYL SULFATE STARCH, CORN TITANIUM DIOXIDE WATER opaque blue cap opaque white body 1389 Droxidopa Droxidopa DROXIDOPA DROXIDOPA FERRIC OXIDE RED FERRIC OXIDE YELLOW FERROSOFERRIC OXIDE GELATIN MAGNESIUM STEARATE MANNITOL POTASSIUM HYDROXIDE PROPYLENE GLYCOL SHELLAC SODIUM LAURYL SULFATE STARCH, CORN TITANIUM DIOXIDE WATER opaque yellow cap opaque white body 1390 Droxidopa Droxidopa DROXIDOPA DROXIDOPA FD&C BLUE NO. 1 FERRIC OXIDE YELLOW FERROSOFERRIC OXIDE GELATIN MAGNESIUM STEARATE MANNITOL POTASSIUM HYDROXIDE PROPYLENE GLYCOL SHELLAC SODIUM LAURYL SULFATE STARCH, CORN TITANIUM DIOXIDE WATER opaque green cap opaque white body 1391

Application Number

ANDA211818

Brand Name

Droxidopa

Generic Name

Droxidopa

Product Ndc

70771-1610

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1609-9 Droxidopa Capsules, 100 mg 90 Capsules Rx only NDC 70771-1610-9 Droxidopa Capsules, 200 mg 90 Capsules Rx only NDC 70771-1611-9 Droxidopa Capsules, 300 mg 90 Capsules Rx only Droxi-100mg-image droxi-200mg-image Droxi-300mg-image

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.